Inspec

Inspec Financial Debt Ratio

The Financial Debt Ratio of Inspec (6656.T) as of Oct 21, 2026 is 59.89 %. In the previous year, Financial Debt Ratio was 55.37 % — a change of 8.17% (higher).

Financial Debt Ratio

59.89 %

YoY

8.17%

Last updated:

Financial Debt Ratio of Inspec is 2026 59.89 % . Financial Debt Ratio of Inspec was 2025 55.37 % . It decreases by 8.17% higher compared to the previous year.

The Inspec Financial Debt Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Debt Ratio
Date
Financial Debt Ratio
Jan 1, 2019
28.42 JPY
Jan 1, 2020
36.69 JPY
Jan 1, 2021
50.10 JPY
Jan 1, 2022
53.93 JPY
Jan 1, 2023
54.97 JPY
Jan 1, 2024
62.11 JPY
Jan 1, 2025
55.37 JPY
Jan 1, 2026
59.89 JPY
The Inspec Financial Debt Ratio history
YEARFinancial Debt RatioYoY
59.89 %+8.17%
55.37 %-10.86%
62.11 %+12.99%
54.97 %+1.93%
53.93 %+7.64%
50.10 %+36.58%
36.69 %+29.08%
28.42 %-37.66%
45.59 %+31.50%
34.67 %-22.47%
44.72 %-12.88%
51.33 %+20.90%
42.46 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

Financial Debt Ratio of Inspec is 59.89 % in 2026.

Financial Debt Ratio of Inspec changed from 55.37 % to 59.89 %, representing a 8.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Debt Ratio Inspec since 2006 – with annual values, charts, and detailed analysis.

The financial debt ratio measures interest-bearing financial debt as a percentage of total assets. It isolates funded debt from trade and other non-financial obligations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Debt Ratio's Inspec with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Inspec

All Key Metrics — Inspec